/
Other
Chronic Pain
47
Pipeline Programs↗
111
Active Trials↗
44
Companies Involved↗
Chronic pain is a moderately active landscape with 47 programs across 44 companies. The most active players are Changchun GeneScience Pharmaceutical Co., Ltd.. 3 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical34
Phase 13
Phase 27
Phase 33
Approved
No programs
Analysis
Trial Status
288
clinical trials
Completed127 · 44%
Recruiting48 · 17%
Not yet recruiting32 · 11%
Active, not recruiting26 · 9%
Unknown status17 · 6%
Terminated15 · 5%
Other23 · 8%
Clinical Trials
Trial Activity
288 trials
Page 1 of 20
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)